Mass Spectrometry for Biomarkers Discovery in Esophageal Squamous Cell Carcinoma

No Thumbnail Available
File version
Author(s)
Islam, F
Gopalan, V
Lam, AK
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2020
Size
File type(s)
Location
License
Abstract

Mass spectrometry-based proteomics analysis could categorize proteins and study their interactions in large scale in human cancers. By this method, many proteins are upregulated or downregulated in esophageal squamous cell carcinoma (ESCC) when compared to nonneoplastic esophageal mucosae. The method can also be used to identify novel, effective biomarkers for early diagnosis or predict prognosis of patients with ESCC. These changes are associated with different clinical and pathological parameters. Different biological matrices such as pathological tissue, body fluids, and cancer cell lines-based proteomics have widely been used. Herein, we described cell line-based label-free shotgun proteomics (in-solution tryptic digestion) to identify the protein biomarkers differently expressed in ESCC.

Journal Title

Methods in Molecular Biology

Conference Title
Book Title
Edition
Volume

2129

Issue
Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Other chemical sciences

Biochemistry and cell biology

Medicinal and biomolecular chemistry

Biomarkers

Cancer

ESCC

Label-free proteomics

Shotgun proteomics

Persistent link to this record
Citation

Islam, F; Gopalan, V; Lam, AK, Mass Spectrometry for Biomarkers Discovery in Esophageal Squamous Cell Carcinoma, Methods in Molecular Biology, 2020, 2129, pp. 259-268

Collections